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Abstract: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic 
syndrome. It affects 20%–30% of the US population, and it is increasing worldwide. Recently, the 
role of lipid-rich maternal gestational nutrition in spurring the development of NAFLD among 
offspring has been indicated. Fetal predisposition to NAFLD involves numerous physiological 
reroutings that are initiated by increased delivery of nonesterified fatty acids to the fetal liver. 
Hampered β-oxidation, uncontrolled oxidative stress, increased triacylglycerol synthesis, and 
the endoplasmic reticulum unfolded protein response are all implicated in sculpting a hepatic 
phenotype with a propensity to develop NAFLD in the postnatal state. This review suggests a 
mechanism that integrates outcomes reported by a variety of studies conducted in an analysis 
of fetal hepatic metabolic capacity amid the maternal consumption of a high-fat diet. Potential 
preventive measures and therapies for use both as part of prenatal nutrition and for those at risk 
for the development of NAFLD are also discussed.
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Introduction
Over the last few decades, metabolic syndrome has become a pervasive epidemic in the 
Western hemisphere, and perhaps surprisingly, this growth is not restricted to developed 
countries.1 Metabolic syndrome consists of a collection of risk factors for cardiovas-
cular disease, encompassing such conditions as obesity, diabetes, and hypertension.1 
Epidemiologists are now witnessing a worldwide spread of metabolic syndrome due 
to the industrialization of developing countries in conjunction with the globalization 
of Western dietary preferences.1 In the US, the National Health and Nutrition Exami-
nation Survey compiled during the years of 2003–2006 showed that 34% of adults 
over the age of 20 years met the criteria for metabolic syndrome, which is based on 
the clinical evaluation of abdominal obesity, plasma triglycerides, blood pressure, and 
fasting blood glucose levels.2 Recently, nonalcoholic fatty liver disease (NAFLD) has 
been adopted as the hepatic manifestation of metabolic syndrome,3 and it is clinically 
defined by triacylglycerol (TAG) storage exceeding 5% of the total liver mass.4
NAFLD affects an estimated 20%–30% of the US population, and 20% of those 
affected will eventually develop nonalcoholic steatohepatitis (NASH). Once an indi-
vidual has NASH, fibrosis is visible in the liver tissue, and the continued presence of 
stressors may elicit the later emergence of cirrhosis or hepatocellular carcinoma.3,5 
Although the etiology of NAFLD is poorly understood, a “two-hit hypothesis” was 
proposed in 1998 by Day and James6 to describe the development of NAFLD and its 
progression to NASH. According to this hypothesis, the first “hit” consists of hepatic 
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insulin resistance or impaired β-oxidation of fatty acids, both 
of which contribute to hepatic lipid accumulation. The second 
“hit” consists of inflammation or oxidative stress, which may 
aggravate the existing steatosis and drive progression into 
NASH.6,7 Recently, it has been proposed that the first “hit” 
can occur in utero due to a maternal diet that is high in fat. 
Indeed, the offspring of such a condition have been shown to 
have a three-fold increase in hepatic TAG shortly after birth.4,8 
This predisposes the offspring to the adult development of 
NAFLD, as only a second “hit” would be needed to spur the 
development of steatohepatitis.
The current literature regarding the contribution of 
prenatal nutrition to the development of NAFLD reveals 
several distinct phenotypic alterations. This review seeks 
to connect these seemingly disconnected outcomes into a 
plausible sequence of events. The underlying questions that 
this review addresses are: 1) in which ways does a lipid-rich 
nutritional environment furnished by the mother interact with 
the biochemical changes occurring within a developing fetus; 
and 2) how may these interactions result in changes in gene 
expression that contribute to an adult phenotype amenable 
to TAG accumulation in the liver? As NAFLD continues to 
extend its reach worldwide, seeking answers to these ques-
tions is essential.
Physiological background
In maternal circulation, plasma concentrations of nones-
terified fatty acids (NEFAs) bound to albumin and TAG 
contained within chylomicrons gradually elevate throughout 
gestation.9 Placental uptake of NEFAs occurs either by dif-
fusion or through a variety of fatty acid transport proteins. 
For chylomicrons, the placenta expresses lipoprotein lipase, 
which cleaves the contained TAG molecules into three NEFAs 
and a glycerol molecule.9 The NEFAs are then free to diffuse 
or be transported via a fatty acid transport protein into fetal 
circulation.
Upon reaching the developing liver, NEFAs diffuse into 
hepatocytes and they are rapidly converted into fatty acyl-
coenzyme A (CoA).10 Primarily, fatty acyl-CoAs enter the 
mitochondria for β-oxidation. This is mediated by the rate-
limiting enzyme, carnitine palmitoyltransferase 1 (CPT1), 
which exchanges the bound CoA for carnitine – yielding 
acyl-carnitine – which can then pass through the outer 
mitochondrial membrane.11 Remaining NEFAs that do not 
undergo β-oxidation will be stored by esterification at the 
endoplasmic reticulum (ER) as TAG.12 TAG may be exported 
within very low-density lipoproteins (VLDL), or TAG may 
be stored within the hepatocyte cytosol in lipid droplets.13,14 
A lipid droplet is an organelle that functions to store TAG 
within a phospholipid membrane comprised chiefly of 
phosphatidylcholine (PC). Since NEFA accumulation is 
toxic to hepatocytes,15 VLDL secretion and lipid droplet 
formation can be regarded as protective measures against 
hepatotoxicity.16
If the liver as a whole attains more fatty acids than it 
eliminates via β-oxidation or VLDL secretion, TAG accu-
mulates in lipid droplets,10 and this represents the defining 
characteristic of NAFLD. In a model of lipid-rich prenatal 
nutrition, the generalized pathway followed by NEFAs, as 
described above, is perturbed in a manner that affects the 
offspring’s physiology into adulthood, and induces a lifelong 
predisposition for NAFLD.
Methods
Many of the studies reviewed here used mice as their model 
organism and the researchers apportioned a maternal pre-
natal diet to one group of dams with a higher composition 
of dietary lipids than that received by the control group. 
Although not uniform amongst all studies, control groups 
were fed a commercial “standard chow” diet containing 
macronutrients distributed aptly for the nutritional needs of 
mice. Increased consumption of dietary lipids is a frequent 
nutritional misallocation in the common Western diet; hence, 
what can be learned from these studies has the potential to 
be readily implemented and appreciated.
However, a significant and inherent limitation of this 
research is that increasing the quantity of one macronutrient 
requires decreasing that of another. If the total percentage 
of lipids increases, then the percentage of other nutrients 
falls relative to the total - it is difficult to know whether the 
experimental results can be attributed to an increase of one or 
a decrease in another, or the combination. Additionally, it is 
unlikely that an average “unbalanced” Western diet errs only 
in its total composition of lipids. Although the implications 
of a maternal high-fat (HF) diet explored in this review may 
apply to those mothers who, for example, additionally have a 
vitamin deficiency, whether there exists synergism or antago-
nism between certain dietary imbalances has yet to be explored 
thoroughly, especially in the context of prenatal nutrition.
Disruptions resulting  
from elevated β-oxidation
In a study by Bruce et al,17 the hepatic metabolic capacities of 
four groups of mice that received either a HF or control (C) 
prenatal and postnatal diet were analyzed. The groups were 
designated as C/C, C/HF, HF/C, and HF/HF, in reference to 
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their prenatal/postnatal nutrition.17 This study revealed that 
levels of CPT1, which is the enzyme that mediates the transfer 
of fatty acyl-CoA through the outer mitochondrial membrane 
in the initiation of β-oxidation,11 did not differ among HF/C, 
C/HF, and HF/HF mice, although all three of these groups 
had marginally elevated CPT1 compared to the C/C group.17 
This suggests that in the presence of increased cytosolic fatty 
acids, there is an upper limit to the amount of CPT1 that can 
be produced to accommodate the influx; CPT1 is the rate-
limiting enzyme in this process.11
The increase in NEFAs in fetal circulation, which is a 
result of the quantity of maternal dietary lipids, was met 
with a corresponding slight escalation in fetal β-oxidation, as 
described by Byrne et al.18 Strikingly, this study determined 
that at 15 weeks of age, the HF/C and HF/HF groups exhibited 
a 3.7- and 3.2-fold respective decrease in electron transport 
chain (ETC) complex I activity compared to the C/C group, 
and the C/HF group did not vary significantly from the C/C 
group in this regard.18
Complex I of the ETC is notorious for the leakage of 
 reactive oxygen species (ROS) (Figure 1).19 Byrne et al18 
hypothesize that increased ROS leakage from complex I, which 
directly results from the increased rates of fetal β-oxidation, 
causes mitochondrial deoxyribonucleic acid (mtDNA) dam-
age. This could potentially reduce the postnatal mitochondrial 
capacity for β-oxidation, as mtDNA lacks the shielding histone 
structure that nuclear deoxyribonucleic acid (DNA) is afford-
ed.18 Albeit reasonable, this explanation neglects to consider 
the C/HF group’s unaffected complex I activity – if higher 
β-oxidation is the initiating event that results in downstream 
damage, as the authors assert, it remains unexplained why the 
C/HF group did not display decreased ETC complex I activity 
comparable to that of the HF/C and HF/HF groups.
Cytotoxic damage produced by sufficient ROS is often 
referred to as oxidative stress. In several models of oxidative 
stress, it has been demonstrated that a cell may selectively 
shunt metabolites from the methionine cycle (Figure 2), down 
the transsulfuration pathway at the expense of s-adenosyl-
methionine in order to increase the synthesis of glutathione 
(GSH), a scavenger of ROS, in an effort to combat oxidative 
stress.20,21 Independently, Bravo et al22 showed that in rats 
fed a HF diet, expression of the enzymes cystathionine 
β-synthase (CBS) and cystathionine γ-lyase, which par-
ticipate in the transsulfuration pathway, were significantly 
downregulated.22 CBS is a necessary enzyme that is involved 
in the redirection of homocysteine from the methionine cycle 
toward GSH synthesis, which occurs in the first step of the 
transsulfuration pathway.21 In conjunction with pressure to 
generate GSH to neutralize ROS, homocysteine levels are 
elevated (Figure 2).
Increased homocysteine levels lead to the downregulation 
of many antioxidant enzymes,23 including GSH peroxidase 1, 
by directly interfering with translation.24 In 2011, Zhang 
et al25 determined that offspring of mice fed a HF diet dur-
ing gestation had decreased expression of the antioxidant 
enzymes GSH peroxidase 1, superoxide dismutase 1, and 
paraoxonases 1, 2, and 3. Although this group did not sug-
gest a reason for this downregulation, they did expound 
upon the consequences of the resultant lowered threshold 
for oxidative stress in the absence of adequate endogenous 
defenses. It is possible that mild hyperhomocysteinemia, 
due to the downregulation of CBS and the diversion of 
methionine cycle metabolites down the transsulfuration 
pathway, is responsible for the downregulation of antioxidant 
enzymes, as noted by Zhang et al.25 In the study by Byrne18 
discussed earlier, the mice fed a C diet in utero and a HF 
diet postnatally (C/HF) did not display altered ETC complex 
I activity, and it is possible that this is because their levels 
of ROS-neutralizing antioxidant enzymes were not down-
regulated during development and, consequently, mtDNA 
damage did not occur.
Disruptions resulting  
from triacylglycerol storage
In hepatocytes, NEFAs that are not accommodated by CPT1 
will be esterified to form TAG, which may be packaged into 
a VLDL particle and exported, or they may be stored within 
the cytosol of the hepatocyte in a lipid droplet.13,14 The stor-
age of TAG within a hepatocyte may be precipitated by four 
independent factors: 1) increased NEFAs in hepatocytes due 
to increased delivery of NEFAs or de novo lipogenesis; 2) 
increased rates of TAG synthesis; 3) reduced levels of VLDL 
export; or 4) decreased capacity for β-oxidation.11 Given that 
TAG accumulation exceeding 5% of the total liver weight is 
the defining criterion for the presence of NAFLD set forth by 
the American Association for the Study of Liver Diseases,4 
presented here is a potential mechanism that connects excess 
hepatocyte cytosolic NEFAs with the derailing of lipid syn-
thesis regulation by the ER, resulting in the accumulation of 
TAG within lipid droplets.
The ER produces acyl-CoA synthetase, which activates 
NEFAs in the cytosol by converting NEFAs into fatty acyl-
CoAs to allow for entrance into the ER, where the fatty 
acyl-CoAs will serve as substrates for lipid synthesis.12 
Furthermore, due to the increased delivery of cytoplasmic 
NEFAs that results from a maternal lipid-rich diet, some of 
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the TAG will be stored in lipid droplets adjacent to the ER.14 
For reasons incompletely understood, sustained increases in 
cytosolic NEFA concentration – and especially increases in 
saturated NEFAs – beget ER stress and, subsequently, the 
induction of the unfolded protein response (UPR) in both 
mice and in the yeast, Saccharomyces cerevisiae.26 The exist-
ing discussion of NEFA-induced ER stress in the literature 
often elects to cover the downstream effects of ER stress, 
rather than investigate the mechanism responsible for its 
appearance; here, both will be addressed.
Triacylglycerol Lipolysis
Synthesis
Fatty acid synthesis
β-oxidation
Phospholipids
Fatty acyl-CoA
Acetyl-CoA
TCA cycle
NADH
ROS
ROS
ROS
ROS
FADH2
Electron
transport chain
ATP synthesis
TAG synthesis
Figure 1 Generalized pathway of lipid metabolism. 
Notes: Cytoplasmic nonesterified fatty acids are rapidly converted to fatty acyl-CoA, which may proceed to undergo β-oxidation or serve as a substrate for either TAG 
or phospholipid synthesis. Following β-oxidation, acetyl-CoA enters the tricarboxylic acid cycle; the produced NADH and FADH2 participate in the ETC. Complex I of the 
ETC leaks injurious ROS. 
Abbreviations: TAG, triacylglycerol; CoA, coenzyme A; TCA, tricarboxylic acid; NADH, nicotinamide adenine dinucleotide; FADH2, flavin adenine dinucleotide; ROS, 
reactive oxygen species; ATP, adenosine triphosphatase; ETC, electron transport chain.
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When TAG is synthesized for storage in a lipid droplet, 
this presents to the hepatocyte the additional challenge of 
producing PC for the lipid droplet membrane.27 While the 
ER membrane contains a specific ratio of PC and phosphati-
dylethanolamine (PE), the preferential phospholipid coat 
for lipid droplets is PC; due to its properties as a surfactant, 
PC maintains the integrity and prevents the coalescence 
of adjacent lipid droplets. When PC is replaced with PE, 
neighboring lipid droplets rapidly merge.28 Fu et al27 assert 
that in order to produce PC, the genes Pemt and Pcyt1a are 
activated. Pemt is a s-adenosylmethionine-dependent meth-
yltransferase that converts existing PE into PC by way of 
sequential methylation, and it is only significantly expressed 
in the liver.27 Pcyt1a encodes the more ubiquitous synthesizer 
of PC, CTP:phosphocholine cytidylyltransferase.29
Membrane composition is a determinant of many bio-
physical properties of a cell or an organelle,30 and upon 
producing PC for lipid droplets, the specific PC/PE ratio in 
the ER membrane is threatened and may rise.15,28 Although 
the mechanism is incompletely understood, an elevated PC/
PE ratio in the ER membrane causes spontaneous dysfunction 
of sarco/ER calcium adenosine triphosphatase (SERCA), and 
returning the ratio to its initial state improves SERCA func-
tion.31 SERCA maintains a significant calcium gradient; the 
concentration of calcium within the ER is nearly 10,000 times 
greater than in the cytoplasm.15 Proper SERCA function is 
crucial not only for maintaining low cytosolic calcium for 
the purpose of signaling events that may include a controlled 
release of calcium, but it is also important because many of 
the chaperone proteins in the ER lumen – such as binding 
immunoglobulin protein (also known as GRP78), calreticulin, 
and calnexin – are calcium-dependent.32,33 Impaired SERCA 
function thus impedes the ability of calcium-dependent chap-
erones to properly fold proteins.34,35 Additionally, the increase 
in cytosolic calcium concentration further aggravates mito-
chondria and contributes to additional oxidative stress.32
The accumulation of unfolded or misfolded proteins in the 
ER lumen defines ER stress and activates the UPR, a series 
of intracellular signaling events that function to restore ER 
homeostasis.36 These events culminate in reducing the ability 
of proteins to enter the ER for posttranslational modifications, 
upregulation of chaperone proteins and, if homeostasis can-
not be restored, apoptosis.15 ER stress and the UPR have two 
implications that directly contribute to the predisposition of 
offspring to NAFLD:
1. Upon induction of the UPR, activating transcription  factor-6 
(ATF6) – one of the proteins that participates in UPR intra-
cellular signal transduction – is activated by intramembrane 
proteolysis. ATF6 shares its proteolytic machinery with 
sterol response element binding protein 1c (SREBP-1c),36 
so upon cleavage of ATF6, SREBP-1c is also cleaved and 
is able to translocate to the nucleus.37 SREBP-1c is a tran-
scriptional activator for the lipogenic proteins, acetyl-CoA 
carboxylase (ACC) and glucokinase.10
2. ER stress also activates the c-Jun N-terminus kinase (JNK) 
pathway, which leads to the phosphorylation of certain ser-
ine residues in insulin receptor substrate-1 (IRS-1). Given 
that the docking of IRS-1, the subsequent tyrosine phospho-
rylation, and the release of IRS-1 is a necessary occurrence 
in successful insulin signaling, serine phosphorylation of 
IRS-1 blocks signal transduction and contributes to hepatic 
insulin resistance.38,39 Hepatic insulin resistance has been 
independently demonstrated to overactivate SREBP-1c.40
SREBP-1c activates the transcription of ACC and 
glucokinase, which both contribute to postnatal fatty 
acid synthesis.10,37,40 However, the presence of both ACC 
Methionine
s-adenosylmethionine
s-adenosylhomocysteine
Adenosine
Homocysteine
Serine
Cystathionine
CystathionaseA-ketobutyrate
Cysteine
Glycine
Glutathione
Glutathione synthetase
Glutamine γ-glutamylcysteine ligase
γ-glutamylcysteine
Cystathionine β-synthase
Figure 2 The methionine cycle and transsulfuration pathway.
Notes: Glutathione synthesis begins with the conversion of homocysteine into 
cystathionine, which is dependent on the presence of both serine and cystathionine 
β-synthase. As the expression of cystathionine β-synthase is downregulated in 
response to a high-fat diet, unconverted homocysteine may accumulate. Adapted 
from Free Radical Biology and Medicine, 43(7), Hitchler MJ, Domann FE, An 
epigenetic perspective on the free radical theory of development, 1023–1036, 
Copyright 2007, with permission from Elsevier.20
Hepatic Medicine: Evidence and Research 2014:6submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
20
Hughes and Oxford
and  glucokinase are complicated in a HF intrauterine 
 environment. ACC converts acetyl-CoA into malonyl-CoA 
which, in addition to playing a key role in de novo lipogenesis, 
is a potent inhibitor of CPT1 and thus decreases the rate of 
β-oxidation (Figure 3).10 Additionally, it has been shown that 
the fetal liver is more sensitive than the liver of a newborn to 
the inhibitory effects of malonyl-CoA.9 In fact, in a maternal 
HF diet experiment performed by Ashino et al,4 82-day-old 
offspring of dams who consumed a diet deriving 45% of its 
caloric value from nondescript fats had higher levels of acti-
vated ACC than did offspring of mice fed a control diet, which 
indicates that the elevation of ACC persists in the postnatal 
state. Since Nagle et al11 included decreased β-oxidation 
as one of the four factors that directly contributes to TAG 
accumulation in the liver, it is probable that malonyl-CoA 
contributes to the predisposition of offspring to NAFLD.
Glucokinase participates in the first step of fatty acid 
synthesis by phosphorylating glucose, resulting in glucose-
6-phosphate.41 Trophoblasts ordinarily express numerous 
glucose transporters from maternal to fetal circulation, such 
that glucose is readily available for the fetus.9 Additionally, it 
has been demonstrated in a rodent model that the placentas of 
mothers who consume a HF diet express a five-fold increase 
in glucose transporter-1, which facilitates the diffusion of 
 glucose into the fetal circulation.42 The increased expression of 
glucokinase in conjunction with an elevated influx of  glucose 
may additionally contribute to de novo lipogenesis.
As NEFAs are produced by the de novo lipogenesis, in 
which both malonyl-CoA and glucokinase participate, and 
since ER stress was initiated with excessive NEFAs entering the 
ER for lipid synthesis, this process can be perceived as cyclic. 
Certainly, the NEFAs produced by de novo lipogenesis could 
Synthesis of PC
for lipid droplets
NEFA delivery to 
fetal hepatic ER
Fetal
downregulation
of CBS
Homocysteine
levels elevate
Shunting of
metabolites
toward transsulfination
pathway to
produce GSH Downregulation
of antioxidant
enzymes
Oxidative stress
Increased
production of
ROS
Fetal hepatic
β-oxidation of
fatty acyl-CoA
Malonyl-CoA and
glucokinase drive
fatty acid
synthesis
SREBP-1c
cleaved, JNK
activation
ER stress,
induction of
UPR
Deficient
calcium
retention
SERCA
dysfunction
ER PC:PE ratio
increases
Maternal high-fat
gestational diet
Figure 3 Sequence of physiological changes resulting from a maternal lipid-rich diet. 
Notes: The left cycle demonstrates how NEFA activation and packaging by the ER results in ER stress, which then spurs the activation of fatty acid synthesis – as part of 
de novo lipogenesis – and synthesized fatty acids may be taken up again by the ER for TAG synthesis. Cytosolic calcium agitates mitochondria and contributes to additional 
oxidative stress, in addition to the stress that results from β-oxidation, visible on the right.32
Abbreviations: PC, phosphatidylcholine; CBS, cystathionine β-synthase; ER, endoplasmic reticulum; PE, phosphatidylethanolamine; NEFA, nonesterified fatty acid; 
SERCA, sarco/endoplasmic reticulum calcium adenosine triphosphatase; GSH, glutathione; UPR, unfolded protein response; CoA, coenzyme A; SREBP-1c, sterol regulatory 
element-binding protein 1c; JNK, Janus kinase; ROS, reactive oxygen species; TAG, triacylglycerol.
Hepatic Medicine: Evidence and Research 2014:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
21
Lipid-rich diet and NAFLD
instead undergo β-oxidation, but as their synthesis requires 
nicotinamide adenine dinucleotide phosphate,9 this would 
be more energetically expensive than to reserve β-oxidation 
for exogenous, maternally-derived NEFAs. Additionally, the 
inhibition of β-oxidation by malonyl-CoA, and the potential 
mtDNA damage caused by rampant ROS, both encourage the 
continuation of NEFAs in the cycle.
Management of NAFLD: prenatal 
and postnatal, present and future
Given the multifaceted nature of TAG accumulation borne 
in utero, it may seem likely that many opportunities exist for 
therapeutic interjection. Presently, omega-3 polyunsaturated 
fatty acids (n-3 PUFAs) and genistein have evidence to support 
their intake as part of preventative maternal prenatal nutrition. 
Novak et al43 performed a study whereby two groups of dams 
were fed the same total amount of dietary fat, but the composi-
tion of dietary fats differed between the groups. Each received 
different fats but both had the same total amount of dietary fat. 
On postnatal day 3, the offspring of the group that received 
adequate n-3 PUFAs displayed higher levels of proteins that 
were integral to mitochondrial β-oxidation, including CPT1, 
and they downregulated genes associated with fatty acid syn-
thesis, compared to the group that received inadequate n-3 
PUFAs.43 It appears that supplementation of n-3 PUFAs as part 
of proper prenatal nutrition, which is reflective of this finding, 
may be a possible preventative route for NAFLD. However, in 
conflict with this proposition is evidence proposed by Dennery 
in 2010,44 who claimed that maternal PUFA supplementation 
causes oocyte mitochondria to increase their ROS production, 
which leads to impaired embryonic development. In adults with 
NAFLD, supplementation with docosahexaenoic acid, an n-3 
PUFA, has been shown to reduce the rates of de novo lipogen-
esis via the negative regulation of SREBP-1c transcription.45 
Perhaps a conciliatory solution lies in the timing of n-3 PUFA 
supplementation; questions with such therapeutic potential 
warrant additional investigation.
Genistein, a soy isoflavone found in soybeans, has received 
more consistent favorable literature reviews than n-3 PUFAs. 
When provided concurrently with a maternal HF diet and 
comprising 0.2% (by weight) of total maternal nutrition, the 
offspring displayed significantly less hepatic TAG accumula-
tion and elevated levels of GSH when compared to offspring 
that solely received a maternal HF diet.46 As GSH produc-
tion is regulated in response to ROS levels, it is possible that 
genistein supplementation ameliorated these defenses and 
prevented the downstream hepatotoxic effects of uncontrolled 
ROS. Additionally, in an adult HF feeding study conducted by 
Ji et al,47 genistein supplementation embodied the qualities of 
an anti-inflammatory compound and appreciably decreased 
the serum levels of the cytokines, tumor necrosis factor-alpha 
and interleukin 6. As inflammation provides the “second hit” 
that drives the transition from NAFLD into NASH, the anti-
inflammatory effects of genistein may prevent or attenuate 
the development of NASH. Ji et al47 also noted that genistein 
is a tyrosine kinase inhibitor, and they implicated this char-
acteristic as the cause of the marked inhibition of the JNK 
pathway observed in response to genistein supplementation. 
Activation of the JNK pathway is implicated in the develop-
ment of hepatic insulin resistance and subsequent overactiva-
tion of SREBP-1c.39,40 Preventing these outcomes in utero by 
supplementing the prenatal diet with genistein may improve 
the offspring’s hepatic phenotype. It is also encouraging that 
these improvements in inflammation occurred in the postnatal 
environment, as they represent a potential degree of revers-
ibility for those born at risk for the development of NAFLD.
Certainly with the number of factors that contribute to the 
development of NAFLD, additional therapeutic avenues for 
preventing TAG accumulation have yet to be discovered. An 
experimental approach of conjugating the lipophilic cation, 
triphenylphosphonium, to an antioxidant such as vitamin E or 
ubiquinone has been shown to permit the delivery of the antioxi-
dant moiety through the mitochondrial membrane.48,49 When this 
approach was described by Murphy and Smith in 2007,48 it was 
their intention to employ the lipophilicity of triphenylphospho-
nium to ensure diffusion of the antioxidant into the mitochondria, 
where ROS neutralization is most useful in relegating oxidative 
stress. Recently, Finichiu et al49 confirmed that this form of anti-
oxidant delivery does indeed reach mitochondria in the tissues 
with high levels of oxidative stress. Although this mechanism 
has only been investigated in general models of oxidative stress, 
given the role of ROS in the development of NAFLD, future 
advances may render this an applicable method of antioxidant 
delivery for those affected by NAFLD.
There is a need for a clearly defined, ideal prenatal diet 
that considers the negative implications of the HF diet dis-
cussed here, and there is also the need for a diet for those 
affected by NAFLD. The American Dietetic Association 
does not currently suggest a recommended daily allowance 
of fats for pregnant women.50 Current research is exploring 
many different diet and exercise regimes for those living 
with NAFLD, with mixed results.51,52 Future work needs to 
ascertain the maximum daily allowance for dietary fats when 
undesirable outcomes for the fetus arise. This will allow for 
the development of dietary guidelines that could easily be 
followed by expecting mothers.
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The diagnostic approach to NAFLD in childhood has 
recently been developed by the European Society of Paediatric 
Gastroenterology, Hepatology, and Nutrition committee.53 
The gold standard for the detection of NAFLD is through liver 
biopsy, but this should only be performed after less invasive 
procedures to rule out other conditions. Testing for appropri-
ate biomarkers and imaging by magnetic resonance imaging 
or ultrasound are noninvasive and fairly reliable diagnostic 
tools for adults and older children, and these methods may 
also be developed for infants.
Conclusion
Education aimed at promoting a balanced prenatal diet 
may be an effective intervention in convincing expecting 
mothers to consider nutrition as equally important to the 
health of a fetus as abstaining from tobacco use and alcohol 
consumption. Previous efforts to educate women on the harm-
ful consequences of these activities during pregnancy have 
been met with success.9 A voluntary decrease in smoking and 
drinking alcohol by pregnant women was demonstrated fol-
lowing these efforts, which was indicative of a willingness by 
women to modify their lifestyle for the benefit of their babies.9 
As the metabolic syndrome has garnered significant attention 
from public health organizations in Western countries, the 
recent acceptance of NAFLD as the hepatic manifestation of 
metabolic syndrome will likely spur its inclusion in future 
public health educational efforts.
Of adults who present with NAFLD, most display sig-
nificant mtDNA abnormalities and mutations, and it has 
been estimated that about 26% of hepatic TAG in NAFLD 
patients is derived from de novo lipogenesis.10,21 In the context 
of elevated maternal dietary lipids, it is clear that both de 
novo lipogenesis and esterification of delivered NEFAs are 
encouraged in the fetus via multiple mechanisms discussed 
herein: damaged mtDNA and associated reduced capacity for 
β-oxidation; the inhibition of CPT1 by malonyl-CoA; and 
the inadvertent activation of SREBP-1c during the unfolded 
protein response. The resultant phenotype of the offspring 
whose mothers consumed a lipid-rich diet during pregnancy 
shares many commonalities with that of adult NAFLD, and 
as illustrated in this review, it predisposes offspring for the 
later development of NAFLD.
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